ArticleFrontiers in oncology2022

SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer.

Lirui Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.